{"id":"placebo-for-ivermectin-cream-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"As a placebo, it does not interact with any biological systems or molecular targets. It is used as a control in clinical trials to compare the efficacy of active treatments.","oneSentence":"This is a placebo, meaning it has no active therapeutic effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:15.456Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of rosacea"}]},"trialDetails":[{"nctId":"NCT05819983","phase":"PHASE4","title":"Ivermectin/ Permethrin for Scabies","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2023-01-25","conditions":"Scabies","enrollment":60},{"nctId":"NCT03075891","phase":"PHASE4","title":"Oracea Soolantra Association in Participants With Severe Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2017-07-05","conditions":"Rosacea","enrollment":273},{"nctId":"NCT02616250","phase":"PHASE4","title":"MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2015-12","conditions":"Rosacea","enrollment":190},{"nctId":"NCT04106726","phase":"PHASE3","title":"Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea","status":"COMPLETED","sponsor":"Zydus Worldwide DMCC","startDate":"2019-10-17","conditions":"Facial Rosacea","enrollment":525},{"nctId":"NCT02036229","phase":"PHASE3","title":"Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2014-02","conditions":"Demodicidosis, Rosacea","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for Ivermectin cream 1%","genericName":"Placebo for Ivermectin cream 1%","companyName":"Zydus Worldwide DMCC","companyId":"zydus-worldwide-dmcc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo, meaning it has no active therapeutic effect. Used for Treatment of rosacea.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}